Mack David Henry 4
4 · PMV Pharmaceuticals, Inc. · Filed Nov 13, 2023
Insider Transaction Report
Form 4
Mack David Henry
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2023-10-18$0.53/sh+198,407$105,156→ 363,877 total - Gift
Common Stock
2023-11-10−85,307→ 278,570 total - Gift
Common Stock
2023-11-10+85,307→ 165,307 total(indirect: See footnote) - Exercise/Conversion
Employee Stock Option (right to buy)
2023-08-07−198,407→ 109,459 totalExercise: $0.53Exp: 2025-05-11→ Common Stock (198,407 underlying)
Holdings
- 147,915(indirect: See footnote)
Common Stock
- 56,978(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F2]The shares are held of record by The Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F3]The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F4]The shares subject to the option are fully vested and immediately exercisable.